نتایج جستجو برای: رده سلولی el4
تعداد نتایج: 18453 فیلتر نتایج به سال:
A blockade of CD44 can interfere with haematopoietic and leukemic stem cell homing, the latter being considered as a therapeutic option in haematological malignancies. We here aimed to explore the molecular mechanism underlying the therapeutic efficacy of anti-CD44. We noted that in irradiated mice reconstituted with a bone marrow cell transplant, anti-CD44 exerts a stronger effect on haematopo...
مقدمه: تریآزنها ترکیباتی هستند که کاربردهای فراوانی در زمینههای مختلف ازجمله تولید داروهای ضد سرطانی دارند. هدف این پژوهش بررسی اثرات ضدسرطانی ترکیب جدیدی به نام 1-(3و5-دی کلروفنیل)-3-(2-اتوکسی فنیل) تریآزن بر روی تومورهای پستانی القا شده توسط رده سلولی 4T1 در موش بالغ نژاد Balb/C بود. روش بررسی: رده سلولی سرطانی 4T1 کشت داده شده و با غلظتهای مختلف ترکیب تریآزنی جدید در مدت زمان 24 ساعت ت...
مقدمه: متاستاز ، عامل اصلی مرگهای با منشأ سرطان پستان است که علیرغم پیشرفتهای علمی اخیر، تغییرات ژنتیکی و مکانیسمهای مولکولی درگیر در متاستاز سرطان پستان هنوز بهطور کامل شناخته نشدهاند. مدلهای حیوانی مناسبی نیز برای بررسی مسیرهای سلولی و ژنهایی که بهطور اختصاصی در جریان متاستاز سرطان نقش دارند، وجود ندارند. در مطالعه اخیر، مدل متاستازی سرطان پستان موشی با استفاده از رده سلولی 4t1 ایجاد ...
Human lymphoblastic leukemia cells of line CEM-C7 are glucocroticoid-sensitive and contain glucocorticoid receptors of wild-type characteristics. EL4 mouse lymphoma cells are resistant to lysis by glucocorticoids due to mutant receptors that exhibit abnormal DNA binding. Hybrids between the two cell lines were prepared and analyzed with respect to glucocorticoid responsiveness and to receptor t...
The murine EL4 lymphoma cell line exists in variants that are either sensitive or resistant to the tumor promoter phorbol 12-myristate 13-acetate (PMA). In sensitive EL4 cells, PMA causes robust Erk mitogen-activated protein kinase activation that results in growth arrest. In resistant cells, PMA induces minimal Erk activation, without growth arrest. PMA stimulates IL-2 production in sensitive,...
Axl is an oncogenic receptor tyrosine kinase that plays a role in many cancers. LIGHT (Lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells) is a ligand that induces robust anti-tumor immunity by enhancing the recruitment and activation of effector immune cells at tumor sites. We observed that mouse EL4 and human Jurkat T lymphom...
The role of complement in antibody therapy of cancer is in general poorly understood. We used the EL4 syngeneic mouse model of metastatic lymphoma to investigate the role of complement in immunotherapy directed against GD2, a target of clinical relevance. IgG2a and IgM anti-GD2 therapy protected EL4-challenged mice from metastases and prolonged survival. Expression of CD59, an inhibitor of dire...
As a potential means for facilitating studies of NK cell-related molecules, we examined the expression of these molecules on a range of mouse tumor cell lines. Of the lines we initially examined, only EL4 and RMA expressed such molecules, both lines expressing several members of the Ly49 and NKRP1 families. Unexpectedly, several of the NK-related molecules, together with certain other molecules...
Immunization of mice with tumors genetically engineered to express the B7 costimulatory molecules amplifies the antitumor immune response mediated by CD8+ cytolytic T lymphocytes (CTL). In this report, we examined the effect of B7-CD28 costimulation on the hierarchy of tumor epitopes. Using a combination of affinity chromatography/reversed-phase high performance liquid chromatography and CTL cl...
Cannabinoid receptors negatively regulate adenylate cyclase through a pertussis toxin-sensitive GTP-binding protein. In the present studies, signaling via the adenylate cyclase/cAMP pathway was investigated in the murine thymoma-derived T-cell line, EL4.IL-2. Northern analysis of EL4.IL-2 cells identified the presence of 4-kilobase CB2 but not CB1 receptor-subtype mRNA transcripts. Southern ana...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید